A monoclonal antibody to the human HER3 receptor inhibits Neuregulin 1-beta binding and co-operates with Herceptin in inhibiting the growth of breast cancer derived cell lines

2011 ◽  
Vol 134 (1) ◽  
pp. 53-59 ◽  
Author(s):  
Edith Blackburn ◽  
Stefania Zona ◽  
Mariana L. Murphy ◽  
Ian R. Brown ◽  
Samuel K. W. Chan ◽  
...  
2014 ◽  
Vol 32 (3) ◽  
pp. 1218-1224 ◽  
Author(s):  
HOISEON JEONG ◽  
JINKYOUNG KIM ◽  
YOUNGSEOK LEE ◽  
JAE HONG SEO ◽  
SUNG RAN HONG ◽  
...  

1994 ◽  
Vol 72 (05) ◽  
pp. 762-769 ◽  
Author(s):  
Toshiro Takafuta ◽  
Kingo Fujirmura ◽  
Hironori Kawano ◽  
Masaaki Noda ◽  
Tetsuro Fujimoto ◽  
...  

SummaryGlycoprotein V (GPV) is a platelet membrane protein with a molecular weight of 82 kD, and one of the leucine rich glycoproteins (LRG). By reverse transcription-polymerase chain reaction (RT-PCR), GPV cDNA was amplified from mRNA of platelets and megakaryocytic cell lines. However, since there are few reports indicating whether GPV protein is expressed in megakaryocytes as a lineage and maturation specific protein, we studied the GPV expression at the protein level by using a novel monoclonal antibody (1D9) recognizing GPV. Flow cytometric and immunohistochemical analysis indicated that GPV was detected on the surface and in the cytoplasm of only the megakaryocytes in bone marrow aspirates. In a megakaryocytic cell line UT-7, GPV antigen increased after treatment with phorbol-12-myri-state-13-acetate (PMA). These data indicate that only megakaryocytes specifically express the GPV protein among hematopoietic cells and that the expression of GPV increases with differentiation of the megakaryocyte as GPIb-IX complex.


Sign in / Sign up

Export Citation Format

Share Document